AFLIBERCEPT-AYYH

AFLIBERCEPT-AYYH was reported 101 times

These side effects are most commonly reported by patients taking AFLIBERCEPT-AYYH:

# Side effect Count
0 TREATMENT FAILURE 9
1 COUGH 6
2 ENDOPHTHALMITIS 6
3 EYE PAIN 6
4 OFF LABEL USE 6
5 REFUSAL OF TREATMENT BY PATIENT 5
6 DEVICE PHYSICAL PROPERTY ISSUE 4
7 DRUG INEFFECTIVE 4
8 HEADACHE 4
9 UVEITIS 4
10 BLINDNESS UNILATERAL 3
11 CEREBROVASCULAR ACCIDENT 3
12 DEATH 3
13 DIABETES MELLITUS 3
14 DIARRHOEA 3
15 DRUG INTOLERANCE 3
16 DRY EYE 3
17 FATIGUE 3
18 INTERCEPTED PRODUCT ADMINISTRATION ERROR 3
19 NEEDLE ISSUE 3
20 VISION BLURRED 3
21 ACCIDENTAL EXPOSURE TO PRODUCT 2
22 DEVICE USE ERROR 2
23 DYSPNOEA 2
24 EYE DISORDER 2
25 EYE IRRITATION 2
26 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2
27 INJECTION SITE PAIN 2
28 INTERCEPTED PRODUCT PREPARATION ERROR 2
29 METAMORPHOPSIA 2
30 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 2
31 NERVOUSNESS 2
32 OCULAR HYPERAEMIA 2
33 PRODUCT SUBSTITUTION ISSUE 2
34 VISUAL IMPAIRMENT 2
35 ABDOMINAL PAIN UPPER 1
36 ADVERSE EVENT 1
37 AGGRESSION 1
38 AMNESIA 1
39 ANXIETY 1
40 ARTHRALGIA 1
41 ASTHENIA 1
42 ASTHMA 1
43 BACK PAIN 1
44 BLINDNESS 1
45 BLINDNESS TRANSIENT 1
46 BLOOD CHOLESTEROL INCREASED 1
47 BORDERLINE GLAUCOMA 1
48 CATARACT NUCLEAR 1
49 CHEST PAIN 1
50 CHOROIDAL NEOVASCULARISATION 1
51 CONTRAINDICATED PRODUCT ADMINISTERED 1
52 CORNEAL ABRASION 1
53 DEAFNESS 1
54 DEPRESSED MOOD 1
55 DEVICE DIFFICULT TO USE 1
56 DEVICE LOOSENING 1
57 DIALYSIS 1
58 DISABILITY 1
59 DIZZINESS 1
60 DRUG DOSE OMISSION BY DEVICE 1
61 DRUG EFFECT LESS THAN EXPECTED 1
62 ELECTROCARDIOGRAM ABNORMAL 1
63 EPIRETINAL MEMBRANE 1
64 EXPOSURE VIA SKIN CONTACT 1
65 EYE HAEMORRHAGE 1
66 EYE INFLAMMATION 1
67 EYELID FUNCTION DISORDER 1
68 EYELID OEDEMA 1
69 FACIAL PAIN 1
70 FEELING ABNORMAL 1
71 GAIT INABILITY 1
72 GASTRIC ULCER 1
73 HAEMOPTYSIS 1
74 HAIR GROWTH ABNORMAL 1
75 HERPES SIMPLEX 1
76 HORDEOLUM 1
77 HYPERAEMIA 1
78 HYPERTENSION 1
79 HYPOAESTHESIA 1
80 ILL-DEFINED DISORDER 1
81 ILLNESS 1
82 INCORRECT DOSE ADMINISTERED 1
83 INFLAMMATION 1
84 INJECTION SITE INFECTION 1
85 INTENTIONAL DOSE OMISSION 1
86 IRIDOCYCLITIS 1
87 LACRIMATION INCREASED 1
88 LOSS OF CONSCIOUSNESS 1
89 LOWER LIMB FRACTURE 1
90 LYMPHOMA 1
91 MACULAR DEGENERATION 1
92 MACULOPATHY 1
93 MALIGNANT NEOPLASM PROGRESSION 1
94 MEDICAL PROCEDURE 1
95 MEMORY IMPAIRMENT 1
96 MIDDLE CEREBRAL ARTERY STROKE 1
97 MUSCLE SPASMS 1
98 MYOCARDIAL INFARCTION 1
99 NEUROPATHY PERIPHERAL 1
100 NO ADVERSE EVENT 1
101 OCULAR HYPERTENSION 1
102 ONYCHALGIA 1
103 ONYCHOCLASIS 1
104 OPTIC DISC DRUSEN 1
105 OXYGEN SATURATION DECREASED 1
106 PHOTOPHOBIA 1
107 PNEUMONIA 1
108 POLLAKIURIA 1
109 PRESYNCOPE 1
110 PRODUCT DOSE OMISSION ISSUE 1
111 PRODUCT LABEL CONFUSION 1
112 PRODUCT LABEL ISSUE 1
113 PRODUCT STORAGE ERROR 1
114 PRODUCT USE IN UNAPPROVED INDICATION 1
115 PRODUCTIVE COUGH 1
116 PUNCTATE KERATITIS 1
117 RETINAL DETACHMENT 1
118 RETINAL DRUSEN 1
119 RETINAL EXUDATES 1
120 RETINAL HAEMORRHAGE 1
121 RETINAL OCCLUSIVE VASCULITIS 1
122 RETINAL VASCULAR DISORDER 1
123 RETINITIS 1
124 RETINOPATHY 1
125 RETINOPATHY HYPERTENSIVE 1
126 RHEUMATOID ARTHRITIS 1
127 SCOLIOSIS 1
128 SNEEZING 1
129 SPINAL OSTEOARTHRITIS 1
130 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1
131 THROMBOSIS IN DEVICE 1
132 URINARY TRACT INFECTION 1
133 VITREOUS DEGENERATION 1
134 VITREOUS HAEMORRHAGE 1
135 VITRITIS 1
136 WEIGHT DECREASED 1
137 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1